As of 2026-08-24, BIOMERICA INC (BMRA) has a 3-month relative strength percentile of 13 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 38. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.0%, relative volume 1.32×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
BMRA appears in 1 ETF as of Mar 2026: VXF at 0.00% weight, $31K notional.
Held by 1 ETFs · $31K across latest filings · largest weight 0.00% (VXF).
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $31K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BMRA Jan avg: 6.61% median: -8.10% win: 25% σ: 41.95% n: 4 2022-04-12 → 2026-07-31 | BMRA Feb avg: 13.58% median: 10.59% win: 50% σ: 29.24% n: 4 2022-04-12 → 2026-07-31 | BMRA Mar avg: -20.87% median: -26.79% win: 25% σ: 15.71% n: 4 2022-04-12 → 2026-07-31 | BMRA Apr avg: -16.64% median: -20.19% win: 20% σ: 13.63% n: 5 2022-04-12 → 2026-07-31 | BMRA May avg: -3.35% median: -2.58% win: 40% σ: 10.22% n: 5 2022-04-12 → 2026-07-31 | BMRA Jun avg: -13.02% median: -17.43% win: 20% σ: 13.69% n: 5 2022-04-12 → 2026-07-31 | BMRA Jul avg: -8.93% median: -4.15% win: 20% σ: 10.97% n: 5 2022-04-12 → 2026-07-31 | BMRA Aug avg: 13.58% median: 12.38% win: 50% σ: 19.51% n: 4 2022-04-12 → 2026-07-31 (current) | BMRA Sep avg: -14.23% median: -17.57% win: 25% σ: 19.42% n: 4 2022-04-12 → 2026-07-31 | BMRA Oct avg: 2.44% median: 6.07% win: 50% σ: 14.39% n: 4 2022-04-12 → 2026-07-31 | BMRA Nov avg: -2.42% median: -0.20% win: 50% σ: 9.74% n: 4 2022-04-12 → 2026-07-31 | BMRA Dec avg: 3.51% median: 1.30% win: 50% σ: 23.91% n: 4 2022-04-12 → 2026-07-31 |